A connection between visceral lipomatosis and protease inhibitors and lipoatrophy and nucleoside reverse transcriptase inhibitors has been hypothesised.
Hüpoteesina on esitatud seost vistseraalse lipomatoosi ja proteaasi inhibiitorite ning lipoatroofia ja nukleosiid- pöördtranskriptaasi inhibiitorite vahel.